Eye health and quality of life: an umbrella review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 08 2020
Historique:
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 19 3 2021
Statut: epublish

Résumé

Vision impairment and eye disease are major global health concerns and have been associated with increased morbidity and mortality, and lower quality of life. Quality of life, whether generic, vision-specific or disease-specific, is an important measure of the impact of eye health on people's daily activities, well-being and visual function, and is increasingly used to evaluate the impact of ophthalmic interventions and new devices. While many studies and reviews have examined the relationship between vision or eye health and quality of life across different contexts, there has yet to be a synthesis of the impact of vision impairment, eye disease and ophthalmic interventions on quality of life globally and across the lifespan. An umbrella review of systematic reviews will be conducted to address these two questions: (1) What is the association of vision impairment and eye disease with quality of life? (2) What is the impact of ophthalmic interventions on quality of life? A search of related literature will be performed on the 11 February 2020 in Medline Ovid, Embase.com, Cochrane Database of Systematic Reviews, Proquest Dissertations and Theses Global, and the grey literature, and repeated at the synthesis stage. Title/abstract and full-text screening, methodological quality assessment and data extraction will be conducted by reviewers working independently and in duplicate. Assessment of methodological quality and data extraction will be performed using Joanna Briggs Institute standard forms. Findings from the systematic reviews and their methodological quality will be summarised qualitatively in the text and using tables. No ethical approval is required. Results of this umbrella review will be published in a peer-reviewed journal and summarised in the This protocol was registered in the Open Science Framework Registries (https://osf.io/qhv9g/).

Identifiants

pubmed: 32868362
pii: bmjopen-2020-037648
doi: 10.1136/bmjopen-2020-037648
pmc: PMC7462163
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037648

Subventions

Organisme : Wellcome Trust
ID : 207472/Z/17/Z
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : K23 EY027848
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG052640
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Psychol Health Med. 2015;20(3):296-310
pubmed: 25034616
Eye (Lond). 2014 Jun;28(6):637-45
pubmed: 24625379
PLoS One. 2015 Jul 20;10(7):e0132779
pubmed: 26192763
Ophthalmology. 2008 Nov;115(11):1973-81
pubmed: 18584873
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Ophthalmic Epidemiol. 2009 Mar-Apr;16(2):128-35
pubmed: 19353401
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
BMC Med Res Methodol. 2019 Nov 4;19(1):203
pubmed: 31684874
Disabil Rehabil. 2012;34(12):971-81
pubmed: 22066708
Psychol Health Med. 2019 Apr;24(4):383-401
pubmed: 30328707
Pharmacoeconomics. 2002;20(12):791-812
pubmed: 12236802
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2308-12
pubmed: 15980215
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Qual Life Res. 2019 Dec;28(12):3225-3236
pubmed: 31401749
Br J Ophthalmol. 2018 May;102(5):593-598
pubmed: 28903966
Ophthalmology. 2012 Sep;119(9):1731-6
pubmed: 22683060
Ophthalmology. 2010 Oct;117(10):1900-7, 1907.e1
pubmed: 20570364
Int J Evid Based Healthc. 2015 Sep;13(3):132-40
pubmed: 26360830
Ophthalmology. 2013 Feb;120(2):415-22
pubmed: 23149127
BMJ Open. 2016 Dec 2;6(12):e011504
pubmed: 27913556
BMC Med. 2014 Oct 17;12:181
pubmed: 25603915
Adv Ther. 2016 Jun;33(6):959-81
pubmed: 27138604
Ophthalmology. 2011 Jul;118(7):1310-7
pubmed: 21458074
Ocul Surf. 2016 Apr;14(2):144-67
pubmed: 26733111
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Ophthalmic Epidemiol. 2016 Jun;23(3):145-53
pubmed: 27159347
Surv Ophthalmol. 2019 Jul - Aug;64(4):512-557
pubmed: 30703405
JAMA Ophthalmol. 2016 Sep 1;134(9):959-66
pubmed: 27466983
Qual Life Res. 2019 Aug;28(8):2017-2039
pubmed: 30879245
BMC Public Health. 2014 Aug 08;14:815
pubmed: 25103270
J Multidiscip Healthc. 2014 Apr 17;7:173-8
pubmed: 24790455
BMC Ophthalmol. 2012 Jul 16;12:22
pubmed: 22799274
Eye (Lond). 2016 Sep;30(9):1251-9
pubmed: 27391939
Eye (Lond). 2010 Sep;24(9):1486-91
pubmed: 20489740
Am J Ophthalmol. 2014 Apr;157(4):799-806
pubmed: 24388838
Arch Ophthalmol. 2005 Jun;123(6):807-14
pubmed: 15955982
Trials. 2015 Sep 11;16:406
pubmed: 26362541
Patient Relat Outcome Meas. 2019 Jan 24;10:9-24
pubmed: 30774489
BMJ Open. 2019 Jun 9;9(6):e029700
pubmed: 31182456
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):71-6
pubmed: 14691156
Br J Ophthalmol. 2008 May;92(5):612-5
pubmed: 18296505
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
Br J Ophthalmol. 2017 May;101(5):686-690
pubmed: 27565988

Auteurs

Lama Assi (L)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Lori Rosman (L)

Welch Medical Library, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Fatimah Chamseddine (F)

Clinical Research Institute, American University of Beirut Faculty of Medicine, Beirut, Lebanon.

Perla Ibrahim (P)

Department of Ophthalmology, American University of Beirut Faculty of Medicine, Beirut, Lebanon.

Hadi Sabbagh (H)

Department of Ophthalmology, American University of Beirut Faculty of Medicine, Beirut, Lebanon.

Nathan Congdon (N)

Centre for Public Health, Queen's University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK.
Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.

Jennifer Evans (J)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.

Jacqueline Ramke (J)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.
School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand.

Hannah Kuper (H)

International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine, London, UK.

Matthew J Burton (MJ)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.
Cornea & External Eye Disease, Moorfields Eye Hospital, London, UK.

Joshua R Ehrlich (JR)

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.

Bonnielin K Swenor (BK)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA bswenor@jhmi.edu.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH